Home» Circulars» Viewcirculars Back
 
Review of SIONS - production and consumptio​n data to be submitted to DGFT before 31.07.2014
 

PxlHeaderLogo

Ref: PXL/H.O./CIR-022/2014-15                                                                Date: 14.07.2014

Review of some SIONS by DGFT

Dear Sir/Madam,

Sub: Review of SIONS - production and consumption data to be submitted to DGFT before 31.07.2014

 

We understand from the Public Notice of DGFT that the following SIONS pertaining to Chemical and Allied Products are being reviewed:

 

Sl. No.

SION No.

Product name

1

A-197

DL Naproxen

2

A -311

Naproxen Sodium

3

A -312

Naproxen Sodium (from N-Methyl Glucamine Route)

4

A -313

Naproxen Sodium (from Tartaric Acid Route)

5

A-321

Omeprazole

6

A-322

Omeprazole Pellets 8.5%

7

A-323

Omeprazole Pellets 8.5%

8

A-2407

2-(Hydroxy Methyl) 3,5, Dimethyl-4- Methoxy Pyridine     (Omeprazole Intermediate)

9

A-2684

2-Chloromethyl-3, 5-Dimethyl-4-Methoxy Pyridine Hydrochloride

10

A-2797

Atorvastatin Calcium

11

A -2943

Naproxen

12

A -2944

Naproxen (from N-Methyl Glucamine Route)

13

A -2945

Naproxen (from Tartaric Acid Route)

14

A -2984

2-Acetyl 6-Methoxy Naphthalene

 

 

 It is understood from the notification that manufacturers of above products are required to submit necessary production and consumption data in ANF 4B for such revision by 31.07.2014.  Non-compliance in providing the data to them would result in stoppage of the benefit of Advance Authorization/DFIA for exports.  We enclose herewith copy of the Notification for immediate reference of members.

 

We, therefore, advise the manufacturers of above products to take immediate note of the notification and submit the data as required by DGFT.  A copy of the reply may be sent to Pharmexcil at info@pharmexcil.comto enable us recommend the SION norms requested by the members.

 

With regards

 

Dr. P V Appaji

Director General

 

Encl:

DGFT NOTIFICATION

H.O.: 101, Aditya Trade Centre, Ameerpet, Hyderbad-500038
Tel: +91-40-23735462/66, Fax: +91-40-23735464
Email: info@pharmexcil.com Website: www.pharmexcil.com